Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance
- PMID: 18299442
- DOI: 10.2337/dc07-2194
Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance
Abstract
Objective: Severe insulin resistance is associated with high morbidity. Identification of severely insulin-resistant patients who have genetic or acquired insulin receptor dysfunction may aid therapeutic decision making; however, onerous diagnostic tests allied to a low frequency of insulin receptor dysfunction often preclude formal diagnosis. Our previous observation of paradoxical hyperadiponectinemia in insulin receptoropathy provides a possible basis for a simpler and cheaper screening test.
Research design and methods: Receiver operating characteristics analysis was used to determine diagnostic thresholds for insulin receptoropathy in severe insulin resistance for adiponectin and for the insulin-regulated hepatic proteins sex hormone-binding globulin (SHBG) and IGF binding protein-1 (IGFBP-1).
Results: Adiponectin >7 mg/l in severe insulin resistance had a 97% positive predictive value for insulin receptoropathy and <5 mg/l a 97% negative predictive value. IGFBP-1 and SHBG had lesser, though still significant, utility.
Conclusions: Use of these markers is likely to have significant value in accelerating the diagnosis of insulin receptoropathies.
Similar articles
-
Elevated plasma adiponectin in humans with genetically defective insulin receptors.J Clin Endocrinol Metab. 2006 Aug;91(8):3219-23. doi: 10.1210/jc.2006-0166. Epub 2006 May 16. J Clin Endocrinol Metab. 2006. PMID: 16705075
-
Characterisation of adiponectin multimers and the IGF axis in humans with a heterozygote mutation in the tyrosine kinase domain of the insulin receptor gene.Eur J Endocrinol. 2012 Mar;166(3):511-9. doi: 10.1530/EJE-11-0790. Epub 2011 Dec 21. Eur J Endocrinol. 2012. PMID: 22189999
-
Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies.Diabetes. 2007 Jun;56(6):1712-7. doi: 10.2337/db06-1665. Epub 2007 Feb 26. Diabetes. 2007. PMID: 17325257 Free PMC article.
-
Adiponectin and leptin in human severe insulin resistance - diagnostic utility and biological insights.Biochimie. 2012 Oct;94(10):2172-9. doi: 10.1016/j.biochi.2012.01.021. Epub 2012 Feb 4. Biochimie. 2012. PMID: 22342226 Review.
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
Cited by
-
Pathogenesis of the metabolic syndrome: insights from monogenic disorders.Mediators Inflamm. 2013;2013:920214. doi: 10.1155/2013/920214. Epub 2013 May 21. Mediators Inflamm. 2013. PMID: 23766565 Free PMC article. Review.
-
Metabolic hormones are integral regulators of female reproductive health and function.Biosci Rep. 2024 Jan 31;44(1):BSR20231916. doi: 10.1042/BSR20231916. Biosci Rep. 2024. PMID: 38131197 Free PMC article. Review.
-
Syndromes of autoantibodies to the insulin receptor.Int J Biochem Mol Biol. 2022 Dec 15;13(6):87-91. eCollection 2022. Int J Biochem Mol Biol. 2022. PMID: 36721839 Free PMC article. No abstract available.
-
Case report: Allogeneic stem cell transplantation for type B insulin resistance.Front Med (Lausanne). 2023 Aug 29;10:1200037. doi: 10.3389/fmed.2023.1200037. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37706022 Free PMC article.
-
Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis.Circ Cardiovasc Genet. 2017 Dec;10(6):e001837. doi: 10.1161/CIRCGENETICS.117.001837. Circ Cardiovasc Genet. 2017. PMID: 29237687 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous